Back to Top Skip to main content

Army researchers developing Zika vaccine

Reference materials on display at a mosquito specimen sorting table. The materials show different stages of insect development in addition to both male and female samples, providing a guideline for specimen assortment.  (U.S. Air Force photo by Senior Airman Mozer O. Da Cunha) Reference materials on display at a mosquito specimen sorting table. The materials show different stages of insect development in addition to both male and female samples, providing a guideline for specimen assortment. (U.S. Air Force photo by Senior Airman Mozer O. Da Cunha)

Recommended Content:

Zika Virus | Medical Research and Development

Researchers at Walter Reed Army Institute of Research in Silver Spring, Maryland, moved quickly to develop and begin testing a Zika vaccine candidate early this year. The fast-moving virus, which is transmitted by infected mosquitos and through sexual contact, alarmed the world as it spread through South and Central America, causing serious birth defects. A preclinical study published June 28 in the journal Nature indicated the feasibility of a vaccine to prevent Zika infection in humans. The study was completed by WRAIR and collaborators at the Beth Israel Deaconess Medical Center at Harvard Medical School.

The WRAIR and Harvard teams are now testing this vaccine in a second preclinical model. If everything goes well, the plan is to start human testing later this year. On July 6, WRAIR announced a cooperative research and development agreement with Sanofi Pasteur to transfer its vaccine technology to the pharmaceutical company to explore advanced and larger-scale manufacturing and production.

"The Army has an interest in supporting development of countermeasures against Zika," said Dr. George V. Ludwig, acting principal assistant for research and technology for the U.S. Army Medical Research and Materiel Command. "Infectious diseases have traditionally been the greatest threat to Soldier health and readiness both in the field and in the garrison. …Similarly, it's also important to support the health and welfare of our Soldier-dependent population here in the United States by finding ways to protect them from this emerging disease."

The mosquitoes that transmit Zika virus, Aedes aegypti, are also the ones responsible for spreading the dengue, yellow fever and chikungunya viruses. These mosquitoes, and the viruses they carry, have been expanding their geographic reach. Until last year, Zika was limited to the tropics of the Indian Ocean basin and the South Pacific. The wide range of A. aegypti and their ability to breed anywhere there is even a tiny amount of stagnant water makes them hard to control. That's why prevention strategies are needed that are directed at the mosquito as well as the human host.

Although Zika manifests clinically in only 20 percent of those infected and generally causes a mild disease of self-limited fever and muscle or joint pain, the virus can cause neurologic disease and death in developing fetuses. Zika virus is also unique among mosquito-borne diseases in that it can be transmitted through sexual contact.

However, a vaccine that limits the amount of virus in the blood will likely prevent transfer of the virus from mother to child or between sexual partners and interrupt transmission within at-risk populations. 

The Zika virus disease was originally discovered in 1947, in the Zika Forest of Uganda. Dr. Alexander J. Haddow was the first to study the virus after a rhesus monkey developed a fever from the bite of an A. africanus mosquito. 

His grandson, Dr. Andrew D. Haddow, followed in his footsteps to become a virologist at the U.S. Army Medical Research Institute of Infectious Diseases, where he also studies the disease on the other half of the research spectrum--basic research. He and his colleagues are doing the work that lays the foundation for understanding the virus.

"Everyone here understands the gravity of the situation, and the impact that our work will make for not only our service members but also populations around the globe," said Haddow. "Our number one goal is to move good science forward as rapidly as possible."

Disclaimer: Re-published content may have been edited for length and clarity. Read original post.

You also may be interested in...

Top Defense Health Agency R&D official visits NHRC

Article
11/9/2017
SAN DIEGO (Oct. 25, 2017) The Defense Health Agency’s (DHA) acting director for Research and Development, Sean Biggerstaff, left, is greeted by Naval Health Research Center (NHRC) commanding officer, Capt. Marshall Monteville, right, during a recent visit to the command. Biggerstaff is responsible for prioritizing and integrating DHA medical research, development, and acquisition programs across the Military Health System. His directorate also fosters strategic partnerships and transitions medical discoveries to deployable products to enhance the readiness of the military community. During the visit, Biggerstaff learned how NHRC’s mission aligns with DHA’s priorities to improve the health and readiness of U.S. warfighters. (U.S. Navy photo by Regena Kowitz/Released)

The Defense Health Agency’s (DHA) acting director for Research and Development, Sean Biggerstaff, got an in-depth look at the work being done at the Naval Health Research Center (NHRC) to support warfighter health and readiness, Oct. 25.

Recommended Content:

Medical Research and Development

Joint Pathology Center celebrates century of helping military docs confirm diagnoses

Article
9/11/2017
Pamela Baker (left), 88th Diagnostics and Therapeutic Squadron cytology technician, prepares the staining of a patient's tissue sample, while Maj. Luisa Watts (right), 88 DTS pathologist shows 1st Lt. Jeffrey Davey (center) her findings on a screen that connects to the microscope inside the operating room at Wright-Patterson Air Force Base Medical Center, June 26, 2017. Watts examines the tissue sample under the microscope to make a diagnosis of the patient's condition. (U.S. Air Force photo by Michelle Gigante)

The Joint Pathology Center is celebrating 100 years of a repository that helps health care providers get that second opinion on diagnoses

Recommended Content:

Medical Research and Development

NHRC research studies link between injury and fitness

Article
8/31/2017
Graphic from NHRC Public Affairs

Dr. Karen Kelly, a physiologist with the Naval Health Research Center’s (NHRC), discussed her recent work examining the relationship between training requirements, fitness and musculoskeletal injuries, during a breakout session at the Military Health System Research Symposium (MHSRS) Aug. 30.

Recommended Content:

Physical Activity | Medical Research and Development

From the classroom to the fight: Preparing for surgical care on the battlefield

Article
8/30/2017
Bringing expeditionary resuscitation and surgical teams directly to the battlefield reduces time and distance, increasing chances for survival. Made up of experienced surgeons, physicians, and nurses with specialties ranging from general surgery to emergency room care, the teams are equipped to provide crucial surgery procedures out in the field. (U.S. Air Force Photo by Staff Sgt. Kyle Brasier)

Recommended Content:

Health Readiness | Medical Research and Development

Knowledge translation: What is it, how will it help?

Article
8/29/2017
The Military Health System Research Symposium is Defense Department's premier scientific meeting.

Knowledge translation is a process to take medical research findings and put them into evidenced-based treatments in a more timely and useful way

Recommended Content:

Medical Research and Development | Research and Innovation

Lab developed tests help keep military medicine on the leading edge of innovation

Article
7/24/2017
Air Force Staff Sgt. Mari Crespo, a medical laboratory technician, conducts tests on a blood bank unit at Joint Base Langley-Eustis, Virginia, June 26, 2017. A program that allows lab developed tests for purchased care for TRICARE beneficiaries has been renewed. (U.S. Air Force photo/Staff Sgt. Teresa J. Cleveland)

A program that allows coverage of lab developed tests for purchased care for TRICARE beneficiaries has been renewed.

Recommended Content:

TRICARE Health Program | Medical Research and Development

One size no longer fits all: MHS’ approach to individualized medicine

Article
7/7/2017
Dr. Jonathan Woodson, former assistant secretary of Defense for Health Affairs and member of Uniformed Services University of Health Sciences Board of Regents, provided the opening remarks at the recent Precision Medicine Research Conference in Potomac, Maryland. (Uniformed Services University of Health Sciences photo)

Military Health System experts discussed the importance of individualized approach to prevention and treatment, and the need for MHS and Uniformed Services University of Health Sciences to pave the way

Recommended Content:

Preventive Health | Medical Research and Development

Race for the Zika Vaccine: The Army Advantage

Video
4/28/2017
Race for the Zika Vaccine: The Army Advantage

When the Zika virus emerged as a global threat, the Walter Reed Army Institute of Research drew on its deep expertise in protecting Soldiers against malaria, Ebola and other flaviviruses, to develop the ZPIV vaccine in just six months. Watch to learn about the unique capabilities vaccinologists in the U.S. Army brought to the fight against Zika.

Recommended Content:

Zika Virus

Zika Virus Infections in Military Health System Beneficiaries

Infographic
4/17/2017
The introduction and rapid spread of the Zika virus (ZIKV), a Flavivrus of the Flaviviridae family, across the Western Hemisphere have posed a risk of infection to Military Health System (MHS) beneficiaries. This report documents: •	The impact of ZIKV transmission on MHS beneficiaries. •	ZIKV spread to nearly 50 countries and territories within a 17-month period. •	Among affected service members, the Army reported the most Zika cases. •	There have been 156 confirmed cases of Zika in MHS beneficiaries. •	A majority of cases reported exposure in Puerto Rico (n=91, 58.3%). Geographic regions of potential exposure to Zika cases in MHS beneficiaries between 01 Jan – 30 Nov 2016 included: •	Puerto Rico ( 91 cases) •	Caribbean ( 41 cases) •	Central America & Mexico (15 cases) •	South America (6 cases) •	Asia ( 3 cases) •	Unknown (3) •	U.S. Florida (1 case) Cases in Service Members Between 01 Jan – 30 Nov 2016 were: •	Army (48 cases) •	Coast Guard (29 cases) •	Air Force (16 cases) •	Navy (10 cases) •	Marine Corps (7 cases) Although most ZIKV infections are asymptomatic or have a relatively mild illness, the gravity of pregnancy and neurologic issues linked to infection remains a significant impetus for the continued surveillance of ZIKV in the MHS population. For more Zika surveillance and information on signs and symptoms, visit Health.mil/AFHSB

The introduction and rapid spread of the Zika virus (ZIKV), a Flavivrus of the Flaviviridae family, across the Western Hemisphere have posed a risk of infection to Military Health System (MHS) beneficiaries.

Recommended Content:

Armed Forces Health Surveillance Branch | Zika Virus

Human trials begin for Army-developed Zika vaccine

Article
11/15/2016
The Zika virus is transmitted to people primarily through the bite of an infected Aedes species mosquito – Aedes aegypti, shown here, and Aedes albopictus. The same mosquitoes spread dengue and chikungunya viruses. Mosquitoes become infected when they feed on a person already infected with the virus. Infected mosquitoes can then spread the virus to other people through bites. (Centers for Disease Control and Prevention photo by James Gathany)

A Zika vaccine clinical trial began recently at the Walter Reed Army Institute of Research officials announced

Recommended Content:

Zika Virus | Immunization Healthcare | Medical Research and Development

Genome Center tracking and sequencing - making a difference in health care

Article
10/28/2016
Nathan Watt, a research associate at the Uniformed Services University of the Health Sciences, closely monitors data on a next-generation sequencer in The American Genome Center at the university. This sequencing helps pinpoint genetic mutations that could serve as biomarkers, which can better predict disease risks and outcomes. TAGC is one of four academic genome centers in the U.S. and the only genome center in the federal system.  (DoD photo by Sarah Marshall)

The American Genome Center at USU aims to study large populations by quickly sequencing thousands of genomes

Recommended Content:

Medical Research and Development | Technology

A decade of progress in Women’s health, cancer research

Article
10/26/2016
Navy Lt. Cmdr. Denise Thigpen, director, Breast Imaging Center at the Murtha Cancer Center at Walter Reed Bethesda, reads two mammograms of a patient. (Courtesy photo)

New discoveries at the Murtha Cancer Center have researchers encouraged about Women’s cancer research

Recommended Content:

Women's Health | Medical Research and Development | Patient Safety

Office of Naval Research developing new ways to protect injured limbs

Article
10/6/2016
Office of Naval Research Logo

The Office of Naval Research is sponsoring work to develop a breakthrough medical wrap, that will not only cover injured limbs, but also mitigate damage and protect tissue for up to three days

Recommended Content:

Research and Innovation | Medical Research and Development

OPM Guidance on Workplace Flexibilities and Authorities for Dealing with the Zika Virus

Policy

The U.S. Office of Personnel Management (OPM) reminds agencies that a wide range of human resources (HR) policies and flexibilities are available to assist employees and agencies in dealing with the Zika virus. This guidance provides information regarding the leave and other workplace flexibilities and authorities available for these purposes.

  • Identification #: N/A
  • Date: 9/23/2016
  • Type: Guidelines
  • Topics: Zika Virus

Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components

Policy

The U.S. Food and Drug Admnistration is issuing this guidance for blood establishments that collect Whole Blood and blood components for immediate implementation in accordance with 21 CFR 10.115(g)(2).

  • Identification #: N/A
  • Date: 9/23/2016
  • Type: Guidelines
  • Topics: Zika Virus
<< < 1 2 3 4 5 > >> 
Showing results 1 - 15 Page 1 of 5

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing: Download a PDF Reader or learn more about PDFs.